Criteria used in clinical practice to guide immunosuppressive treatment in patients with primary sclerosing cholangitis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Schulze, Kornelius ^a   Weismüller, Tobias J ^b,c   Bubenheim, Michael ^d   Huebener, Peter ^a   Zenouzi, Roman ^a   Lenzen, Henrike ^c   Rupp, Christian ^e   Gotthardt, Daniel ^e   De Leuw, Philipp ^f   Teufel, Andreas ^g,h   Zimmer, Vincent ⁱ   Reiter, Florian P ^j   Rust, Christian ^j   Tharun, Lars ^a   Quaas, Alexander ^a,k   Weidemann, Sören A ^k   Lammert, Frank ⁱ   Sarrazin, Christoph ^f   Manns, Michael P ^c   Lohse, Ansgar W ^a   Schramm, Christoph ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITÉ DE ROUEN   (France)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h UNIVERSITY HOSPITAL REGENSBURG   (Germany)

ⁱ SAARLAND UNIVERSITY   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; IMMUNOGLOBULIN G; URSODEOXYCHOLIC ACID; AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT INDICATION; TREATMENT RESPONSE; BLOOD; CHOLANGITIS, SCLEROSING; CLINICAL TRIAL; COMPLICATION; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; LIVER; LIVER DISEASES; METABOLISM; MULTICENTER STUDY; PATHOLOGY; PROCEDURES;

ADULT; CHOLANGITIS, SCLEROSING; COHORT STUDIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LIVER; LIVER DISEASES; MALE; RETROSPECTIVE STUDIES; TRANSAMINASES;

EID: 84950108350     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140525     Document Type: Article

References (18)

1. Liaskou E, Jeffery LE, Trivedi PJ, Reynolds GM, Suresh S, Bruns T, et al. Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. Gastroenterology. 2014; 147(1):221-32 e7. Epub 2014/04/15. doi: 10.1053/j.gastro.2014.04.003 PMID: 24726754.
2. Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E, et al. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology. 2013; 58 (3):1084-93. Epub 2013/04/09. doi: 10.1002/hep.26447 PMID: 23564624.
3. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of hepatology. 2011; 54(2):374-85. Epub 2010/11/12. doi: 10.1016/j.jhep.2010.09.002 PMID: 21067838.
4. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010; 51(6):2193-213. Epub 2010/06/01. doi: 10.1002/ hep.23584 PMID: 20513004.
5. European Association for the Study of the L. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of hepatology. 2009; 51(2):237-67. Epub 2009/06/09. doi: 10.1016/j.jhep.2009.04.009 PMID: 19501929.
6. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48(1):169-76. Epub 2008/06/10. doi: 10.1002/hep.22322 PMID: 18537184.
7. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. Journal of hepatology. 1995; 22(6):696-9. Epub 1995/06/01. PMID: 7560864.
8. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19(6):1513-20. Epub 1994/06/01. PMID: 8188183.
9. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley; 1980. xi, 321 p. p.
10. Luth S, Herkel J, Kanzler S, Frenzel C, Galle PR, Dienes HP, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. Journal of clinical gastroenterology. 2008; 42(8):926-30. Epub 2008/07/23. doi: 10.1097/MCG.0b013e318154af74 PMID: 18645526.
11. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-78. Epub 2010/01/27. doi: 10.1002/hep.23294 PMID: 20101749.
12. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology. 1996; 23 (6):1369-76. Epub 1996/06/01. doi: 10.1002/hep.510230612 PMID: 8675153.
13. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. Journal of hepatology. 1999; 31(5):929-38. Epub 1999/12/02. PMID: 10580593.
14. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. Journal of hepatology. 2000; 33(4):537-42. Epub 2000/11/04. PMID: 11059857.
15. Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Digestive diseases and sciences. 1996; 41(2):305-14. Epub 1996/02/01. PMID: 8601374.
16. Chandok N, Silveira MG, Lindor KD. Comparing the simplified and international autoimmune hepatitis group criteria in primary sclerosing cholangitis. Gastroenterology & hepatology. 2010; 6(2):108-12. Epub 2010/06/23. PMID: 20567552; PubMed Central PMCID: PMC2886459.
17. Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013; 145(3):521-36. Epub 2013/07/06. doi: 10.1053/j.gastro.2013.06.052 PMID: 23827861; PubMed Central PMCID: PMC3815445.
18. Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. The American journal of gastroenterology. 2005; 100(7):1516-22. Epub 2005/06/30. doi: 10.1111/j.1572-0241.2005.41841.x PMID: 15984974.